JENNIFER PARSONS: Open Payments
NPI 1619933116 · RIPLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 23 payments from 14 companies in 2025. Trend: 2023 $64 · 2024 $572 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Celgene Corporation | 3 | $59 |
| Astellas Pharma US Inc | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $51 |
| ARRAY BIOPHARMA INC | 2 | $46 |
| BeOne Medicines USA, Inc. | 2 | $40 |
| Hologic Sales and Service, LLC | 1 | $24 |
| BeiGene USA, Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $19 |
| Aveo Pharmaceuticals, Inc. | 1 | $18 |
Products named: Enhertu, REBLOZYL, TEVIMBRA, KISQALI, OPDIVO, Padcev, Vyloy, XALKORI.
Industry payments across WV — which companies pay providers there.
